Extended monitoring and biomarker analysis in metastatic melanoma patients treated with TIL therapy and conditioning-replacing igrelimogene litadenorepvec virotherapy: Pre-infusion immune cell and cytokine profiles associated with survival.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Victor Cervera-Carrascon, Tatiana Kudling, James Clubb, Lyna Haybout, Tine Monberg, Santeri Pakola, Benedetta Albieri, Susanna Juteau, Eva Ellebaek, Marco Donia, Victor Arias, Amir Khammari, Claudia Kistler, Elise Jirovec, Dafne Carolina Alves Quixabeira, Suvi Sorsa, Brigitte Dreno, Inge Marie Svane, Akseli Hemminki
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7162570287